Literature DB >> 3338797

Assignment of the human progesterone receptor to the q22 band of chromosome 11.

M G Mattei1, A Krust, U Stropp, J F Mattei, P Chambon.   

Abstract

The human progesterone receptor gene was localized by in situ hybridization to the q22 band of chromosome 11.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3338797     DOI： 10.1007/bf00291245

Source DB:  PubMed          Journal:  Hum Genet        ISSN： 0340-6717            Impact factor:   4.132


  13 in total

1.  A superfamily of potentially oncogenic hormone receptors.

Authors:  S Green; P Chambon
Journal:  Nature       Date:  1986 Dec 18-31       Impact factor: 49.962

2.  Prognostic usefulness of estrogen receptor immunocytochemical assays for human breast cancer.

Authors:  E R DeSombre; S M Thorpe; C Rose; R R Blough; K W Andersen; B B Rasmussen; W J King
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

3.  DNA probe localization at 18p113 band by in situ hybridization and identification of a small supernumerary chromosome.

Authors:  M G Mattei; N Philip; E Passage; J P Moisan; J L Mandel; J F Mattei
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

4.  The c-erb-A gene encodes a thyroid hormone receptor.

Authors:  C Weinberger; C C Thompson; E S Ong; R Lebo; D J Gruol; R M Evans
Journal:  Nature       Date:  1986 Dec 18-31       Impact factor: 49.962

5.  Is a functional estrogen receptor always required for progesterone receptor induction in breast cancer?

Authors:  K B Horwitz
Journal:  J Steroid Biochem       Date:  1981-12       Impact factor: 4.292

6.  Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma.

Authors:  A Dejean; L Bougueleret; K H Grzeschik; P Tiollais
Journal:  Nature       Date:  1986 Jul 3-9       Impact factor: 49.962

7.  Localization of the oncogene c-erbA1 immediately proximal to the acute promyelocytic leukaemia breakpoint on chromosome 17.

Authors:  D Sheer; D M Sheppard; M le Beau; J D Rowley; C San Roman; E Solomon
Journal:  Ann Hum Genet       Date:  1985-07       Impact factor: 1.670

8.  Cloning of the human estrogen receptor cDNA.

Authors:  P Walter; S Green; G Greene; A Krust; J M Bornert; J M Jeltsch; A Staub; E Jensen; G Scrace; M Waterfield
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

9.  Chromosomal localization of the human oncogene ERBA2.

Authors:  J R Gosden; P G Middleton; D Rout; C De Angelis
Journal:  Cytogenet Cell Genet       Date:  1986

10.  Chromosomal localisation of the human homologues to the oncogenes erbA and B.

Authors:  N K Spurr; E Solomon; M Jansson; D Sheer; P N Goodfellow; W F Bodmer; B Vennstrom
Journal:  EMBO J       Date:  1984-01       Impact factor: 11.598
View more
  8 in total

Review 1.  Comparative map for mice and humans.

Authors:  J H Nadeau; M T Davisson; D P Doolittle; P Grant; A L Hillyard; M R Kosowsky; T H Roderick
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

Review 2.  Comparative map for mice and humans.

Authors:  J H Nadeau; M T Davisson; D P Doolittle; P Grant; A L Hillyard; M Kosowsky; T H Roderick
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

3.  Analyze association of the progesterone receptor gene polymorphism PROGINS with ovarian cancer risk.

Authors:  Cunzhong Yuan; Cunfang Wang; Xiaoyan Liu; Beihua Kong
Journal:  Mol Biol Rep       Date:  2013-09-21       Impact factor: 2.316

4.  Mapping of the human retinoic acid receptor to the q21 band of chromosome 17.

Authors:  M G Mattei; M Petkovich; J F Mattei; N Brand; P Chambon
Journal:  Hum Genet       Date:  1988-10       Impact factor: 4.132

5.  Progesterone receptor PROGINS and +331G/A polymorphisms confer susceptibility to ovarian cancer: a meta-analysis based on 17 studies.

Authors:  Ting Liu; Lilan Chen; Xiangjun Sun; You Wang; Shu Li; Xia Yin; Xinran Wang; Chenhuan Ding; He Li; Wen Di
Journal:  Tumour Biol       Date:  2013-11-07

6.  Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women.

Authors:  R L Balleine; M J Earl; M L Greenberg; C L Clarke
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

7.  Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis.

Authors:  A Borg; H Sigurdsson; G M Clark; M Fernö; S A Fuqua; H Olsson; D Killander; W L McGurie
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

8.  A germline TaqI restriction fragment length polymorphism in the progesterone receptor gene in ovarian carcinoma.

Authors:  N J McKenna; D G Kieback; D N Carney; M Fanning; J McLinden; D R Headon
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.